PMID: 24045840

Degiorgio D, Corsetto PA, Rizzo AM, Colombo C, Seia M, Costantino L, Montorfano G, Tomaiuolo R, Bordo D, Sansanelli S, Li M, Tavian D, Rastaldi MP, Coviello DA
Two ABCB4 point mutations of strategic NBD-motifs do not prevent protein targeting to the plasma membrane but promote MDR3 dysfunction.
Eur J Hum Genet. 2014 May;22(5):633-9. doi: 10.1038/ejhg.2013.214. Epub 2013 Sep 18., [PubMed]
Sentences
No. Mutations Sentence Comment
2 ABCB4 p.Leu481Arg
X
ABCB4 p.Leu481Arg 24045840:2:134
status: NEW
view ABCB4 p.Leu481Arg details
Among subjects with cholangiopathies who were screened for mutations in ABCB4 by direct sequencing, we identified the new mutation p.(L481R) in three brothers. Login to comment
3 ABCB4 p.Tyr403His
X
ABCB4 p.Tyr403His 24045840:3:95
status: NEW
view ABCB4 p.Tyr403His details
According to our model of tertiary structure, this mutation affects the Q-loop, whereas the p.(Y403H) mutation, that we already described in two other families, involves the A-loop. Login to comment
7 ABCB4 p.Tyr403His
X
ABCB4 p.Tyr403His 24045840:7:232
status: NEW
view ABCB4 p.Tyr403His details
On the contrary, cholesterol (Chol) release, after 1 and 3 mM sodium taurocholate stimulation, was higher in the mutant-transfected cell lines than that in the wild-type and was particularly enhanced in cells transfected with the p.Y403H-construct.In summary, our data show that both mutations do not seem to affect protein expression, but are able to reduce the efflux of phosphatidylcholine associated with increase of Chol, thereby promoting the formation of toxic bile. Login to comment
31 ABCB4 p.Tyr403His
X
ABCB4 p.Tyr403His 24045840:31:84
status: NEW
view ABCB4 p.Tyr403His details
The nucleotide change c.1207T4C that encodes the mutant protein characterized by p.(Y403H) was previously described at homozygous state in the child of family B and at heterozygous state in the other members of family B and C.14 To evaluate the expression of MDR3 in vitro, we used two plasmids: one containing the full-length cDNA of ABCB4 wild type on a pcDNA3.1/ Hygro( &#fe; ) backbone (pcDNA3.1/Hygro( &#fe; )/ABCB4) and the second containing the b-galactosidase gene (pcDNA3.1.V5/His-lacZ). Login to comment
33 ABCB4 p.Tyr403His
X
ABCB4 p.Tyr403His 24045840:33:89
status: NEW
view ABCB4 p.Tyr403His details
ABCB4 p.Leu481Arg
X
ABCB4 p.Leu481Arg 24045840:33:106
status: NEW
view ABCB4 p.Leu481Arg details
The plasmid pcDNA3.1/Hygro(&#fe; )/ABCB4 was also used to obtain clones harboring the p.(Y403H) or the p.(L481R) mutation. Login to comment
36 ABCB4 p.Leu481Arg
X
ABCB4 p.Leu481Arg 24045840:36:83
status: NEW
view ABCB4 p.Leu481Arg details
Bioinformatic analysis The three-dimensional models of the human MDR3 and of the p.Leu481Arg mutant were built by homology based on the structure of the murine multidrug resistance protein 1A (gene name, Abcb1a), determined with crystallographic methods (PDB: 3g5u).16 The models were built with an automated procedure with the SwissModel web server (http://www. Login to comment
54 ABCB4 p.Leu481Arg
X
ABCB4 p.Leu481Arg 24045840:54:184
status: NEW
view ABCB4 p.Leu481Arg details
RESULTS Molecular analysis and in silico evaluation The sequencing analysis of ABCB4 gene in the members of family A showed a new heterozygous mutation, c.1442T4G, which causes the p.(L481R) amino-acid change. Login to comment
56 ABCB4 p.Leu481Arg
X
ABCB4 p.Leu481Arg 24045840:56:7
status: NEW
view ABCB4 p.Leu481Arg details
The p.(L481R) replaces the hydrophobic Leu side chain with a bulkier and hydrophilic Arg residue in the first NBD. Login to comment
77 ABCB4 p.Leu481Arg
X
ABCB4 p.Leu481Arg 24045840:77:29
status: NEW
view ABCB4 p.Leu481Arg details
(b) Region surrounding the p.Leu481Arg mutation, with the neighboring residues represented in ball-and-stick. Login to comment
80 ABCB4 p.Tyr403His
X
ABCB4 p.Tyr403His 24045840:80:132
status: NEW
view ABCB4 p.Tyr403His details
ABCB4 p.Tyr403His
X
ABCB4 p.Tyr403His 24045840:80:212
status: NEW
view ABCB4 p.Tyr403His details
ABCB4 p.Leu481Arg
X
ABCB4 p.Leu481Arg 24045840:80:110
status: NEW
view ABCB4 p.Leu481Arg details
ABCB4 p.Leu481Arg
X
ABCB4 p.Leu481Arg 24045840:80:190
status: NEW
view ABCB4 p.Leu481Arg details
Wild-type cells secreted more PC and Chol than the mutant ones; PC: 3.417 nmol/mg proteins versus 1.410 for p.L481R and 2.346 for p.Y403H and Chol: 4.476 nmol/mg proteins versus 3.193 for p.L481R and 3.811 for p.Y403H (Figures 4a and b; Supplementary Table 1). Login to comment
82 ABCB4 p.Tyr403His
X
ABCB4 p.Tyr403His 24045840:82:31
status: NEW
view ABCB4 p.Tyr403His details
ABCB4 p.Leu481Arg
X
ABCB4 p.Leu481Arg 24045840:82:93
status: NEW
view ABCB4 p.Leu481Arg details
Although wild-type cells and p.Y403H mutant showed similar fold increases in PC excretion, p.L481R mutant showed higher sensitivity to NaTC reaching 11-fold increase in PC secretion at 3 mM compared with the absence of NaTC (Supplementary Table 1). Login to comment
85 ABCB4 p.Tyr403His
X
ABCB4 p.Tyr403His 24045840:85:17
status: NEW
view ABCB4 p.Tyr403His details
In particular, p.Y403H displayed higher Chol excretion compared with wild-type cells at 3.0 mM NaTC: 9.04 versus 6.05 by referring at parameter 'fold increase` and 34.438 versus 27.074 (nmol/mg proteins) by referring at parameter 'absolute amount`. Login to comment
92 ABCB4 p.Tyr403His
X
ABCB4 p.Tyr403His 24045840:92:64
status: NEW
view ABCB4 p.Tyr403His details
ABCB4 p.Leu481Arg
X
ABCB4 p.Leu481Arg 24045840:92:46
status: NEW
view ABCB4 p.Leu481Arg details
Lanes 5 and 6 show the stable expression of p.L481R-ABCB4 and p.Y403H, respectively. Login to comment
94 ABCB4 p.Tyr403His
X
ABCB4 p.Tyr403His 24045840:94:132
status: NEW
view ABCB4 p.Tyr403His details
The PC/Chol ratio showed a similar trend in absence or with 1.0 and 3.0 mM of NaTC; it was reduced in both mutants, particularly in Y403H cells, whereas an inverted trend was shown after treatment with 0.5 mM NaTC. Login to comment
96 ABCB4 p.Tyr403His
X
ABCB4 p.Tyr403His 24045840:96:36
status: NEW
view ABCB4 p.Tyr403His details
As reported in Figure 4c, in mutant Y403H cells low values of PC efflux are associated with high Chol into the culture medium. Login to comment
98 ABCB4 p.Tyr403His
X
ABCB4 p.Tyr403His 24045840:98:263
status: NEW
view ABCB4 p.Tyr403His details
ABCB4 p.Leu481Arg
X
ABCB4 p.Leu481Arg 24045840:98:82
status: NEW
view ABCB4 p.Leu481Arg details
In this study, besides reporting the identification of a novel ABCB4 mutation (p.(L481R)) within the Q-loop in three siblings suffering from juvenile cholelithiasis, we demonstrate that this mutation, stably transfected in HUH28 cells, as well as the mutation p.(Y403H), previously described by our group,14 do not prevent protein targeting to the plasma membrane but induce an abnormal efflux of PC and Chol. Login to comment
102 ABCB4 p.Tyr403His
X
ABCB4 p.Tyr403His 24045840:102:138
status: NEW
view ABCB4 p.Tyr403His details
ABCB4 p.Leu481Arg
X
ABCB4 p.Leu481Arg 24045840:102:7
status: NEW
view ABCB4 p.Leu481Arg details
The p.(L481R) mutation was identified in three out of seven affected siblings belonging to family A, whereas the already characterized p.(Y403H) mutation6,14 was identified in four affected members belonging to other two families. Login to comment
104 ABCB4 p.Tyr403His
X
ABCB4 p.Tyr403His 24045840:104:52
status: NEW
view ABCB4 p.Tyr403His details
In particular, the infant bearing the homozygous p.(Y403H) mutation was diagnosed as PFIC-3 at the age of 3 months, and at the age of 3 years presented compensated cirrhosis with portal hypertension; (ii) a single mutant allele can be associated with hepatobiliary diseases with less significant and highly variable clinical features. Login to comment
111 ABCB4 p.Tyr403His
X
ABCB4 p.Tyr403His 24045840:111:97
status: NEW
view ABCB4 p.Tyr403His details
ABCB4 p.Leu481Arg
X
ABCB4 p.Leu481Arg 24045840:111:114
status: NEW
view ABCB4 p.Leu481Arg details
Analysis of PC (a) and Chol (b) secretion, and PC-Chol correlation (c) in MDR3 wild-type, MDR3 p.Y403H and MDR3 p.L481R cells. Login to comment
118 ABCB4 p.Tyr403His
X
ABCB4 p.Tyr403His 24045840:118:655
status: NEW
view ABCB4 p.Tyr403His details
As for biliary Chol, it is widely documented that in mice it is excreted into the canalicular lumen through different pathways; among them, a relevant rate of efflux is because of the direct activity of the specific ABC hemitransporters G5 and G8 (ABCG5 and ABCG8).27 Our data show that, in absence or low concentration of NaTC, mutant cells have less Chol efflux ability than wild-type cells, and this direct proportionality between reduced excretion of biliary PC and Chol was originally described in Mdr2/  mice.7 Instead, higher concentrations of NaTC seem to increase Chol efflux by mutant cells, with a maximum value obtained in presence of the p.Y403H mutation so that the ratio between PC and Chol is inverted. Login to comment